Pharmaxi
Private Company
Funding information not available
Overview
Pharmaxi LLC is a private, revenue-generating contract research organization (CRO) providing clinical trial services across Eastern and Central Europe, primarily in Ukraine and Poland. Its core business is the full-service management of late-phase (Phase III-IV) clinical trials and post-marketing studies, supported by its proprietary OnlineCRF platform for efficient data management and site oversight. The company leverages the cost-attractive and patient-rich clinical trial environments of its operating regions, positioning itself as a flexible and innovative partner for sponsors. While it does not develop its own therapeutics, its service model and proprietary technology platform are its key assets.
Technology Platform
Proprietary Electronic Data Capture (EDC) system called OnlineCRF, enabling remote data management, role-based oversight, real-time analytics, and enhanced data quality for clinical trials.
Opportunities
Risk Factors
Competitive Landscape
Pharmaxi competes in the fragmented global CRO market, facing competition from large multinational CROs (e.g., IQVIA, ICON) and numerous regional and niche players in Eastern Europe. Its differentiation is based on deep local expertise in Ukraine/Poland, a flexible service model, and its proprietary OnlineCRF technology platform.